Tetrodotoxin detection in puffer fish by a sensitive planar waveguide immunosensor by Reverte Calvet, Laia et al.
Tetrodotoxin detection in puffer fish by a sensitive planar waveguide
immunosensor
Reverte Calvet, L., Campàs, M., Yakes, B. J., Deeds, J. R., Katikou, P., Kawatsu, K., ... Campbell, K. (2017).
Tetrodotoxin detection in puffer fish by a sensitive planar waveguide immunosensor. DOI:
10.1016/j.snb.2017.06.181
Published in:
SENSORS AND ACTUATORS B-CHEMICAL
Document Version:
Peer reviewed version
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
© 2017 Elsevier Ltd.
This manuscript is distributed under a Creative Commons Attribution-NonCommercial-NoDerivs License
(https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits distribution and reproduction for non-commercial purposes, provided the
author and source are cited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:09. Sep. 2018
 1 
 
Tetrodotoxin Detection in Puffer Fish by a Sensitive Planar Waveguide 
Immunosensor 
 
Laia Revertéa,b, Mònica Campàsb, Betsy Jean Yakesc, Jonathan R. Deedsc, Panagiota 
Katikoud, Kentaro Kawatsue, Michael Lochheadf, Christopher T. Elliotta and Katrina 
Campbella* 
 
a Institute for Global Food Security, School of Biological Sciences, Queen’s University, 
David Keir Building, Stranmillis Road, Belfast, UK BT9 5AG.  
b IRTA, Ctra. Poble Nou, km 5.5, Sant Carles de la Ràpita, Spain. 
c US Food and Drug Administration, Center for Food Safety and Applied Nutrition 
(CFSAN), 5001 Campus Drive, College Park, MD 20740, USA. 
d National Reference Laboratory on Marine Biotoxins, Ministry of Rural Development and 
Food, 54627 Thessaloniki, Greece. 
e Division of Bacteriology, Osaka Prefectural Institute of Public Health, 3-69, Nakamichi 1-
chome, Higashinari-ku, Osaka 537-0025, Japan. 
f MBio Diagnostics Inc., 5603 Arapahoe Avenue, Boulder, Colorado 80303, USA. 
 
Footnote: Laia Revertéa,b, PhD student at IRTA, conducted this work as Visiting 
Researcher at QUB. 
 
Corresponding Author 
Dr Katrina Campbell 
Institute for Global Food Security,  
School of Biological Sciences,  
Queen’s University,  
David Keir Building,  
Stranmillis Road,  
Belfast, UK  
BT9 5AG. 
E-mail: katrina.campbell@qub.ac.uk 
 
 
 
 2 
 
 
Abstract 
A nanoarray planar waveguide biosensor was developed for the detection of tetrodotoxin 
(TTX). This technique, specifically designed for the first time for TTX, provided a compact 
versatile user friendly device that obtained a test result in ten minutes. The device consisted 
of nanoprinted toxin-conjugate arrays constructed in the manner of an indirect competitive 
immunoassay, for the analysis of puffer fish samples under high flow conditions.  The 
applicability to natural samples was investigated through the study of matrix effects and toxin 
recovery. The biosensor enabled the detection of TTX from 0.4 to 3.29 µg g-1 puffer fish 
tissue. The sensitivity attained demonstrates this assay as a rapid and sensitive screening 
method to detect TTX in different species of puffer fish, well below the Japanese maximum 
permitted level (2 µg g-1) and the estimated safety level used in the EU and the US (0.8 µg 
g-1). Assay repeatability and reproducibility were assessed at 0.4 and 0.8 µg g-1, showing 
relative standard deviation (RSD) values below 15% and toxin recovery within 85-115%. 
The appropriate correlation of data obtained from the biosensor compared to that reported 
by ELISA, RBA, SPR biosensor and LC-MS/MS for the analysis of 12 puffer fish samples, 
proved the feasibility and reliability of this immunosensor to support monitoring programs 
and research activities. 
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1. Introduction 
Tetrodotoxin (TTX) is one of the most hazardous low-molecular-weight marine neurotoxins 
[1], whereby poisoning following consumption has a notorious lethal incidence. TTX is 
commonly found in the organs of select puffer fish species, typically the liver, ovaries, and 
gastrointestinal (GI) tract but also occasionally in the meat. TTX is also found in other 
organisms, and this toxin is believed to be exogenously produced, starting from bacteria 
which accumulate up through the food chain into fish, bivalve shellfish, amphibians and 
octopus [2]. Human fatalities from Puffer Fish Poisoning (PFP) are mostly caused by the 
ingestion of puffer fish (“fugu”) in Japan [3], but the presence of TTX has also been reported 
in bivalve shellfish, harvested in several parts of Europe [4-6] and other countries [7, 8]. The 
main symptoms of PFP range from neuromuscular (lips and tongue paraesthesia, tingling 
and numbness) to gastrointestinal (nausea, abdominal pain, vomiting and diarrhea) [9]. 
More severe symptoms consist of uncoordinated movements, muscle spasms, and 
progressive muscle paralysis that can result in respiratory failure in severe intoxication 
cases. TTX toxicity (LD50) is 2-10 µg kg-1 intravenously and 10-14 µg kg-1 subcutaneously 
in mammals as well as 334 µg kg-1 orally in mice [10]. 
TTX and its related analogues are hydrophilic, heat-stable, heterocyclic compounds [11, 12], 
able to selectively block sodium channels [13, 14]. To date, 29 analogues of TTX have been 
described, which when classified according to their structure are: hemylactal, lactone and 
4,9 anhydro types. To the best of our knowledge, little is known about the role that these 
analogues may play in terms of toxicity, with the exception of the study performed by Yotsu-
Yamashita and co-workers in rat membranes where 5,6,1-trideoxy TTX showed less toxicity 
than other analogues [15]. To protect consumers against PFP in Japan, the regulatory limit 
for TTX in food is 2 µg TTX equivalents g-1 [16]. In the US, no guidance level has been 
established, and TTX intoxications from puffer fish are predominantly limited through 
importation restrictions which only allow the puffer fish species Takifugu rubripes from Japan 
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to be brought into the country with additional strict processing guidelines [17]. All other 
imported puffer fish products are subject to automatic detention without physical 
examination by the US Food and Drug Administration (FDA) [18]. Despite these strict import 
restrictions, several cases of PFP have been reported in recent years in the US due to the 
unapproved importation of puffer species [19, 20]. Additionally, no regulatory limits have 
been specifically set for TTX in Europe. However, in both Europe and the US, safety limits 
have been set at 0.8 µg saxitoxin (STX) equivalents g-1 shellfish meat for the 
pharmacologically similar paralytic shellfish poisoning (PSP) toxins. This concentration can 
be used as a guide in determining the role of TTX in incidents of illness. The increasing 
incidence of seafood TTX poisoning episodes in Europe and in other non-regulated regions 
might have relevant consequences to food safety and economic fisheries. Therefore, there 
is a real need for the development of methods suitable to regulate this toxin in food by means 
of routine monitoring, thus, providing sufficient protection to human health and fishery 
products [21]. 
In Europe, the shift for PSP toxins screening in bivalves and seafood from the mouse 
bioassay (MBA) which inadvertently detected TTX toxins, to the method of Lawrence using 
high-performance liquid chromatography with fluorescence detector (HPLC-FLD) [22], 
created a gap in the detection for other important paralytic toxins such as TTX that are 
relevant to food safety and that are not detected by the latter technique. Current methods 
for TTX detection are mainly those based on analytical chemistry, such as HPLC and liquid 
chromatography tandem-mass spectrometry (LC-MS/MS) [23]. Although useful techniques, 
their performance is occasionally hampered by the lack of commercially available analytical 
standards for some TTX analogues and by the requirement of skilled personnel and 
expensive equipment. TTX detection has also been achieved by biochemical methods, 
including immunoassays [24-30] and electrochemical [25, 31] and optical immunosensors 
[32-37], some of these having shown promise not only as research activities but also as 
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screening tools in monitoring programs. Biosensors are increasingly being investigated due 
to the advantages they offer in terms of sensitivity, portability, ease of use and robustness. 
To date, surface plasmon resonance (SPR) immunoassay has been the most widely applied 
biosensor-based method for TTX, though the cost of instrumentation has prevented this 
method’s broader uptake. More recently, another optical biosensor, based on planar 
waveguide technology, is gaining attention, and it has been successfully developed for other 
marine toxins, such as okadaic acid (OA), domoic acid (DA) and saxitoxin (STX) [38], but 
not yet explored for TTX detection. Accordingly, an immunosensor based on the planar 
waveguide technology with fluorescence detection for the determination of TTX is described 
herein. In this technique, waveguide cartridges are previously spotted with picoliter drops of 
the desired toxin-conjugate, and the extent of the molecular interaction upon addition of the 
antibody is determined through a fluorescence reader. In the assay, when toxin is not 
present in a sample, nearly all the primary antibody is bound to the toxin conjugate attached 
on the surface, and a high fluorescence signal is obtained from the secondary antibody. 
When toxin is present in the sample, the antibody binds to this toxin in solution, thereby 
decreasing the amount of primary antibody available to bind to the surface and thus the 
fluorescence signal decreases proportionally to the toxin concentration. The signal itself is 
generated from light that is transmitted from the bottom of the waveguide cartridges, leading 
to the excitation of the fluorophores on the labeled-secondary antibody, thus enabling the 
sensitive recording of binding events on the surface (Figure 1). The aim of this work was to 
investigate this planar waveguide biosensor for the rapid detection of TTX in puffer fish 
samples using a simple extraction method. After development, this biosensor was applied 
to the analysis of samples, and the results were compared to other methods of analysis 
including the MBA, receptor binding assay (RBA), ELISA, SPR biosensor and LC-MS/MS 
analysis. 
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2. Material and methods  
 
2.1 Reagents 
Bovine serum albumin (BSA), casein from bovine milk, phosphate buffered saline (PBS) 
tablets, sodium acetate anhydrous, sodium chloride, sodium phosphate dibasic, sodium 
phosphate monobasic and Tween 20 were purchased from Sigma-Aldrich (Dorset, UK). 
Alexa Flour 647 goat anti-mouse IgG (GaM) antibody and BSA-Alexa Fluor 647 conjugate 
were obtained from Invitrogen Ltd. (Paisley, Scotland). TTX standard was procured from 
Biomol/Affiniti Research Products (Exeter, UK). 
 
2.2 Sample collection 
Seven puffer fish samples (Lessepsian migrant puffer fish Lagocephalus sceleratus) were 
obtained from the National Reference Laboratory for Marine Biotoxins (NRLMB) of Greece. 
Five puffer fish muscle samples (Lagocephalus lunaris), which were previously associated 
with several outbreaks of illness in the US in 2007 [19], were from collaborators at the FDA. 
TTX-free puffer fish muscle from Takifugu rubripes was also provided by FDA and used as 
negative tissue for matrix effects and toxin recovery experiments. 
 
2.3 Sample extraction method 
The extraction method used was previously described by Bates and co-workers [39] for the 
SPR analysis of PSP toxins in shellfish [40]. Briefly, 1 g portions of puffer fish homogenate 
were weighed into 20-mL disposable Sterilin centrifuge tubes, and 4 mL of sodium acetate 
buffer pH 5.0 was added. Each tube was vigorously vortex mixed for 10 s followed by roller 
mixing (STUART SRT9, Bibby Scientific Ltd, UK) at 33 rpm for 30 min. After mixing, samples 
were centrifuged at 3,600×g (SORVALL Legend RT, DJB Labcare Ltd, UK) for 10 min at 
room temperature. The supernatant was decanted, collected, and 40-fold diluted in MBio 
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assay buffer at pH 7.4 (25 μL extract to 975 μL buffer). MBio assay buffer consisted of 1% 
BSA, 0.05% Tween 20, one PBS tablet and 200 mL of distilled water. 
 
2.4 Synthesis of the immunological reagents 
TTX conjugate, TTX-jeffamine-keyhole limpet hemocyanin (TTX-jeff-KLH), was produced by 
combining different methods and with some modifications [24, 41-44]. In brief, jeffamine was 
conjugated initially to KLH via amine coupling in the same manner as that previously 
described for BSA [41]. One mg of TTX and 50 µL of 37% formaldehyde were then added 
to 5 mg of jeff-KLH protein. This mixture was allowed to react for 72 h at room temperature 
followed by dialysis in 0.15 M saline solution (3 x 4 L) over 24 h. The production of 
monoclonal antibody against TTX (mAb) was previously described [24]. Moreover, the mAb 
has been further characterized and used in published works [27, 40]. 
 
2.5 Cartridge spotting and standardized building process 
Microarrays were printed using a sciFLEXARRAYER S5 spotter (Scienion, Germany) 
equipped with a Bio-Jet print head capable of dispensing 25-nL droplets with spot diameters 
of approximately 0.5 mm on the slides in a 2×22-array format. TTX conjugate diluted in 
sterile filtered printing buffer (100 mM sodium phosphate, 50 mM sodium chloride, 100 µg 
mL-1 BSA, 0.005% Tween 20, pH 8.0) was spotted at four concentrations (10, 25, 50, and 
100 μg mL-1) in replicates of two. Upon optimization, 50 and 100 µg mL-1 TTX conjugate 
concentrations were selected and spotted in replicates of four per cartridge for the following 
experiments. In addition, fluorescently labeled BSA conjugate was spotted at 4 µg mL-1 at 
each of the four corners of the array to enable the proper alignment within the SnapESi 
reader. Printing buffer drops were spotted as negative controls between BSA and TTX 
conjugate spots. All printing procedures were performed at room temperature and 65% 
humidity. Printed waveguide arrays were then left at 25 °C and 35% humidity overnight. 
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After this, the waveguide arrays were blocked with casein solution for 5 min, rinsed with 
deionized water and dried by 1,000 rpm centrifugation (SORVALL Legend RT, DJB Labcare 
Ltd, UK) for 5 min. To fit the waveguides on the MBio reader, waveguides were inserted into 
cartridge housing that provided a flow channel of 5-mm-wide, 50-mm-long and 0.145-mm-
high. The building process was completed with the addition of an adsorbent pad and a top 
cover. Cartridge components and the SnapEsi LS system were supplied by MBio 
Diagnostics Inc. (Boulder, Colorado, US). 
 
2.6 Immunosensor protocol 
MBio cartridges were placed on a cartridge rack at a special angle to enhance fluidic flow. 
The protocol was similar to that described by McGrath and co-workers [45]. The Ttotal assay 
time was 10 min. First, 150 µL of 1/500 mAb dilution:standard TTX or sample (1:1, v:v) were 
applied to the cartridge for 5 min, followed by 150 µL of 10 µg mL-1 Alexa Fluor 647 GaM 
IgG solution for 5 min. Each cartridge was then read on the MBio assay reader. Initially, 
different time exposures were collected, ranging from 25 to 100 ms of exposure. After this 
evaluation, readings were recorded at the fixed time point 75 ms after sample addition and 
were exported into Microsoft Excel for data analysis.  
 
2.6.1 Preparation of buffer calibration curves and data analysis 
A stock solution of 1,000 µg L-1 was used to prepare TTX calibrants at concentrations of 0, 
0.5, 1, 2.5, 5, 10 and 100 µg L-1 in MBio assay buffer. These working standards were 
equivalent to 0, 0.08, 0.16, 0.4, 0.8, 1.6 and 16 μg TTX g-1 puffer fish. A calibration curve 
was prepared for each conjugate concentration. Two cartridges (n=2) were used for each 
TTX working standard. Each cartridge consisted of a total of 16 spots, 8 spots per conjugate 
concentration.  
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Curves were normalized with respect to the controls without TTX (0 µg L-1) and fitted to a 
sigmoidal logistic four-parameter equation using SigmaPlot software 12.0 (Systat Software 
Inc., California, US). The concentrations of TTX in the samples were then interpolated from 
these curves. In order to compare the response obtained with both TTX conjugate 
concentrations, data was first tested for normality using the Shapiro-Wilk test. For data 
following a normal distribution, t-test was performed; otherwise, Mann-Whitney Rank Sum 
Test was done. The level of significance was set at p<0.05. Finally, correlation between both 
TTX conjugate concentrations was evaluated using the linear regression model. All statistics 
were carried out using Sigmastat 3.1 software (Systat Software Inc., California, US). 
The sensitivity (IC50) and dynamic range (IC20-IC80) of the assay were determined from the 
calibration curves obtained. The LOD for the present work was defined as the 20% inhibitory 
concentration (IC20), which corresponds to the concentration of toxin required to decrease 
the response by 20% compared to the response when no toxin is present in the system 
(100% mAb binding). 
 
2.7 Evaluation of puffer fish matrix effects and toxin recovery 
For puffer fish matrix calibration curves, aliquots of 1 g of negative puffer fish muscle tissue 
homogenate were fortified with 20 µL of several concentrations of TTX and then extracted. 
Additionally, negative puffer tissue was extracted and then fortified with TTX (50 µL of TTX 
solution to 950 µL MBio assay buffer). With this procedure, puffer fish tissue and puffer fish 
extracts were fortified with TTX at 0, 0.08, 0.16, 0.4, 0.8, 1.6 and 16 μg TTX g-1 puffer fish. 
The spiking protocol was designed for the regulatory limit for PSP of 0.8 μg STX equiv. g-1 
tissue to fall within the middle of the calibration curves pre and post-extraction, thus ensuring 
the capability of the present method to screen TTX effectively at this concentration. Both, 
TTX fortified-puffer fish tissue and extracts were 40-fold diluted in MBio assay buffer and 
then run on the immunosensor for subsequent analysis. Curves were analyzed and 
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compared to that prepared in buffer in order to evaluate the puffer fish matrix effects and to 
measure the TTX recovery under experimental conditions. Sensitivity (IC50) and dynamic 
range (IC20-IC80) of the assay for the three curves were obtained by fitting the data to 
sigmoidal, logistic, four-parameter equations. The LOD, defined previously as the 20% 
inhibitory concentration (IC20), was calculated from an average of two replicates of 
calibration curves. In order to calculate the toxin recovery, mAb binding percentages 
obtained at TTX fortification levels of 0.4 and 0.8 µg g-1 of puffer fish tissue were compared 
to the fortification levels.  
 
2.8 Repeatability studies 
The performance of the method was assessed using the PSP toxin maximum permitted level 
of 0.8 µg STX equivalents (equiv.) g-1 shellfish, since no regulatory limit is currently set within 
EC legislation for TTX. This repeatability study was carried out at two levels of TTX 
fortification (0.8 and 0.4 µg g-1) and by the analysis of 5 replicates (n=5) of a single puffer 
fish sample. Each replicate was extracted and 40-fold diluted in MBio assay buffer for 
analysis. Then, toxin recoveries as well as relative standard deviation (RSD) at each 
fortification level were calculated using the response value obtained from each individual 
analysis. Additionally, the same extracts were reanalyzed the following day, and toxin 
recoveries and RSD values at each fortification level were calculated.  
 
2.9 Puffer fish sample analysis and comparison with analytical, biological and 
biochemical assays, and biosensors 
Different tissues and species of puffer fish (n=12) were analyzed (16 replicates each) by the 
present method using the extraction method previously detailed. Once extracted, samples 
were 40-fold diluted in MBio assay buffer. Specifically, 2 muscle samples, 2 liver samples, 
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2 skin samples and 1 GI tract from 3 individuals of L. sceleratus, and 5 muscle samples from 
5 individuals of L. lunaris were analyzed, and TTX contents expressed in µg g-1 were 
calculated and compared with other analytical techniques. Puffer fish tissues were split into 
two groups, named as set 1 and set 2, according to the other techniques used to analyze 
the samples. Therefore, set 1 includes samples 1-5 (L. lunaris samples), which were 
analyzed by LC-MS/MS, RBA, ELISA and SPR biosensor. Analysis methods and data of 
this first set of samples was previously described in the work performed by Cohen and co-
workers [19] and Yakes and colleagues [46]. Set 2 comprises three different fish (L. 
sceleratus samples) with different tissues: 6 (muscle), 7.A (GI tract), 7.B (liver), 7.C (skin), 
and 8.A (liver), 8.B (skin) and8.C (muscle), previously analyzed by LC-MS/MS and MBA. 
Analysis methods and data of the second set were described in the work performed by 
Katikou and co-workers [47] and Rodríguez and colleagues [48], respectively. Statistics to 
compare data obtained with different methods was performed following the same procedure 
used to compare data from calibration curves of both TTX conjugate concentrations. TTX 
concentrations in these samples was achieved by taking into account the mAb binding 
inhibitory concentration of the sample (within the dynamic range IC20-IC80) from the 
associated calibration curve. Those samples that showed responses above 80% were 
further diluted to bring their fluorescence signals within the dynamic range of the calibration 
curve. 
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3. Results and discussion 
 
Given the increasing concern about the prevalence of TTXs in fish and shellfish products in 
European waters and the high potency of these toxins, increased monitoring through the 
development of rapid, sensitive and robust methods is needed to ensure human health 
protection. With the aim of replacing animal use methods such as the MBA for TTX 
detection, in the present work the development of a sensitive planar waveguide-based 
biosensor able to detect TTX in multiple puffer fish tissues is described. 
 
3.1. Immunosensor protocol optimization 
Following the improved MBio procedure described by McGrath and co-workers [45], TTX-
jeff-KLH conjugate concentration and mAb dilution were firstly optimized. Of the four spotted 
TTX conjugate concentrations (10, 25, 50 and 100 µg mL -1), those that gave a fluorescence 
value below 150 or above 500 when no TTX was present, were discarded. Following this 
criteria, 10 and 25 µg mL -1 TTX conjugate concentrations were no longer used. As such, 
given that the spotting of TTX conjugate at 50 and 100 µg mL-1 provided similar responses, 
both concentrations were selected for comparison in subsequent experiments. The capacity 
of the immobilized TTX conjugates to inhibit the mAb binding response was then assessed 
using 1/250 and 1/500 mAb dilutions at 100 µg L-1 of TTX standard. At both antibody 
dilutions, this TTX concentration was able to completely inhibit the mAb binding. However, 
as a lower antibody concentration generally results in a higher sensitivity, the 1/500 mAb 
dilution was selected for the assay. With the experimental parameters set at TTX conjugate 
spotting concentrations of 50 and 100 µg mL -1, mAb at 1/500 dilution and fluorescently-
labeled GaM IgG antibody at 10 µg mL-1 (concentration set through checkerboard titration 
in the work performed by Meneely and colleagues [49]), the whole calibration curves were 
performed in buffer. 
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3.2 Assay sensitivity determined from buffer calibration curves 
Calibration curves obtained for both TTX conjugate spotting concentrations in MBio assay 
buffer are shown in Figure 2 a and b, and, the midpoint (IC50), limit of detection (LOD) and 
dynamic range determined are shown in Table 1. The IC50 and LOD values were fairly 
similar at both spotting concentrations (P=0.797; T=0.275) with a correlation of y=1.45x-
1.72. A narrower dynamic range was obtained with 100 µg mL-1 of TTX conjugate, likely due 
to the binding kinetics effects of reduced competition in binding with additional coating 
antigen on the arrayed surface. IC50 and LOD values provided by this new immunosensor 
(6.0 and 2.5 µg L-1, respectively), compared well with a previous indirect SPR immunosensor 
that used the same antibody (6.6 and 2.4 µg L-1, respectively) [32], as well as with an SPR 
biosensor that employed a commercial antibody (approximately 6 and 0.3 µg L-1, 
respectively) [33]. Further, the IC50 values of the sensor developed herein were better than 
those recently reported for other indirect SPR immunosensors for TTX on a commercial 
instrument ((IC50 of 28.9 and IC20 of 7.8 µg L-1) [46] and from the average of three 
laboratories (IC50 of 74 and IC20 of 14 µg L-1) [35]). As such, the sensitivity achieved in buffer 
was determined to be suitable for further assay development and the evaluation of matrix 
effects. 
 
3.3. Evaluation of puffer fish matrix effects and toxin recovery 
In order to demonstrate the applicability of the method to the analysis of real samples, matrix 
effects of puffer fish and of the extraction protocol procedure were investigated through 
spiking TTX into puffer fish extracts and into puffer fish fish tissue homogenates, 
respectively. Calibration curves obtained for both TTX conjugate spotting concentrations in 
buffer and in puffer fish matrix fortified pre and post-extraction are shown in figure 2. As the 
curves essentially overlap in the dynamic range of the assay, it can be concluded that there 
were little matrix effects from the puffer fish tissue and extraction procedure when these are 
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diluted and run on the immunosensor. Furthermore, TTX concentrations and toxin 
recoveries obtained pre and post-extraction are shown in Table 2.  
TTX concentrations determined in fortified-puffer fish extracts were similar to those obtained 
in buffer (P=1.000; T=5.000). Statistically, no significant differences were found between the 
50 or 100 µg mL-1 TTX conjugate surfaces for both fortification levels (P=0.667; T=6.000; 
y=0.98x+0.01). These similar results demonstrate that there are negligible puffer fish matrix 
effects on the system. 
With regard to TTX concentrations determined when spiking TTX in puffer fish tissues, 
appropriate recovery values were obtained, and these concentrations were similar to the 
TTX fortification levels (P=1.000; T=5.000). These accurate recovery values demonstrated 
the good efficiency of the extraction protocol and that there were limited toxin losses during 
the extraction process. Again, no significant differences were found between using 50 or 
100 µg mL-1 of TTX conjugate (P=0.667; T=5.500; y=1.03x-0.03). TTX concentrations 
obtained in fortified-puffer fish tissues were also similar to that in fortified-puffer fish extracts 
(P=1.000; T=5.000), reaffirming the negligible matrix effects on the biosensor and that 
accurate results from natural samples could be obtained.  
 
3.4. Repeatability studies 
The five homogenate-tissue samples fortified at 0.8 as well as five at 0.4 µg g-1 extracted 
and analyzed over two days, showed acceptable toxin recovery values. Specifically, results 
expressed in percentage values with respect to the TTX-fortified concentration (0.8 or 0.4 
µg g-1) and determined from the calibration curve in buffer were 89.1 and 78.5% for TTX-
conjugate spotted at 50 µg mL-1 and 106.3 and 106.8% for 100 µg mL-1 of conjugate, 
respectively, on day 1. Similarly, the same extracts reanalyzed on day 2 provided toxin 
recoveries of 81.5 and 97.6% for 50 µg mL-1 of conjugate and 96.6 and 107.3% for 100 µg 
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mL-1 of conjugate. To assess the repeatability of the present sensor, precision was 
expressed as the RSD of the results , according to the 2012 AOAC International Guidelines 
[50]. Hence, on day 1, RSD values with respect to 50 µg mL-1 of TTX conjugate were 14.6% 
for 0.8 µg g-1 and 10.8% for 0.4 µg g-1, while values were 9.9% for the 0.8 µg g-1 and 2.1% 
for the 0.4 µg g-1 for TTX conjugate 100 µg mL-1. On day 2, RSD values were 12.5 and 8.3% 
for 50 µg mL-1 of TTX conjugate and, 10.4 and 13.1 for 100 µg mL-1 of TTX conjugate at 0.8 
and 0.4 µg g -1, respectively. Considering the expected precision as a function of analyte 
concentration, RSD values for 0.8 and 0.4 µg toxin g-1 puffer fish tissue should be lower than 
15%, and all the obtained RSD values for this assay were below this value. It should be 
noted that this was a comparison of extracts between days and not re-extraction of the fish 
due to limitations in toxin availability. Nevertheless, this results illustrate the degree of 
repeatability in analysis. Additionally, the toxin recovery values obtained in same extracts 
on day 2, demonstrate that samples containing TTX were stable at least for 1 day. All these 
results demonstrated that the new planar waveguide biosensor allowed for suitable precision 
under repeatability conditions within independent tests and that already extracted samples 
could be reanalyzed on the following day with the same precision. Additionally, differences 
between values obtained with both TTX conjugate concentrations were statistically not 
significant. The good agreement of the results provided by this repeatability study at 0.8 and 
0.4 µg TTX g-1 fish tissue confirmed the feasibility and reliability of the planar waveguide 
biosensor for being applied to the analysis of real samples. 
 
3.5. Puffer fish samples analysis and comparison with other methods 
Table 3 shows the TTX concentrations determined per g of puffer fish tissue by the 
nanoarray-based biosensor as well as by other analytical and biochemical methods. In 
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general, TTX contents determined in the samples provided by the present biosensor 
correlated well with the data reported by the other methods.  
Among the 12 puffer fish samples analyzed, 4 samples (1 and 5 muscle tissues from 
L.  lunaris, and 8.B (skin) and 8.C (muscle) from L. sceleratus) were found to contain TTX 
contents below the regulated Japanese level of 2 µg TTX g-1 fish tissue by all the techniques. 
With respect to the other samples, within the L. lunaris samples (Set 1, Table 3a), the trend 
from the most to the lowest toxic muscle tissue was: 4 > 3 > 2 > 1 > 5 for all the techniques 
employed. The high concentrations of TTX found in muscle tissue extracts 3 and 4 from L. 
lunaris individuals were in accordance with the high contents of TTX found in the meat of 
this species of puffer fish, which is a causative source of food poisonings worldwide [51]. On 
the contrary, the distribution of TTX found among the L. sceleratus tissues from the most to 
the lowest toxicity was: GI-tract (7.A) > liver (7.B, 8.A) > skin (7.C, 8.B) ≥ muscle (6, 8.C). 
Again, the toxin distribution found within tissues agrees well with that reported for L. 
sceleratus species [3, 52], as the gastrointestinal tract is expected to be the most toxic, 
followed by the liver and finally by the skin and muscle. 
In the analysis of the first set of samples (1-5), excellent correlation was obtained between 
the TTX contents determined by the planar-waveguide biosensor at both conjugate 
concentrations (y=1.06x-0.11; R²=0.996; P=1.000; T=27.500). Because of this similarity 
(differences statistically not significant) and to simplify the results, the comparison with other 
methods was only performed with reference to the 100 µg mL-1 conjugate surface. When 
comparing the quantifications provided by the planar waveguide biosensor with those LC-
MS/MS values reported previously in Cohen and co-workers [19] and Yakes and colleagues 
[46], higher TTX contents were reported by the biosensor with a correlation of y=1.70x-0.08 
(R²=0.987) obtained, although the differences were statistically not significant (P=0.517; 
T=0.677). The higher TTX concentrations in the L. lunaris muscle samples determined by 
the biosensor could be attributed to the fact that the previous LC-MS/MS quantifications for 
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these samples were determined solely for TTX while the mAb used herein may react with 
multiple TTX analogues potentially present in the puffer fish samples. Rodriguez and co-
workers [48] found multiple TTX analogs in the closely related species L. sceleratus, several 
of which were in higher concentration than TTX itself. Most of these analogs are less potent 
than TTX, as evidenced by the poor correlation to MBA data in that study. It is not currently 
known if these same TTX analogs are also present in L. lunaris and what their contributions 
are to total toxicity. This possibility was supported by the correlation obtained by RBA and 
the planar-waveguide biosensor (y=1.32x-0.36; R²=0.994; P=0.757; T=0.320). The high 
TTX concentration achieved by the biosensor in this case could also be due to the different 
affinity between the two biorecognition molecules (mAb for the waveguide and sodium-
channel receptor for the RBA) as well as the final reporting element (fluorescently labeled 
secondary antibody for the waveguide and H3-STX for the RBA). 
The same trend was observed when comparing the waveguide assay data to that obtained 
by ELISA (y=1.12x+0.36; R²=0.933; P=0.489; T=0.725) and SPR immunosensor 
(y=1.70x+0.02; R²=0.986; P=0.510; T=0.690). Although data obtained by the biosensor was 
similar to that obtained by ELISA and SPR immunosensor, small differences in determining 
TTX content can similarly be attributed to differences in biorecognition elements and 
transduction techniques. Specifically, in the SPR biosensor the TTX was chemically 
immobilized on dextran chips, and the signal was measured in real time. In ELISA and the 
waveguide sensor, TTX-conjugate was coated on wells and on nanoarrays, respectively, 
which likely resulted in the slightly different responses. Furthermore, although both ELISA 
and the biosensor are indirect strategies that use a secondary labeled antibody, the final 
output is given by the absorbance of an enzyme in ELISA and by fluorescence in the 
biosensor. Although TTX contents determined by the planar waveguide biosensor were 
slightly higher than those reported by the other techniques, they were still in good 
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agreement. Within this set of samples, the trend from higher to lower TTX concentrations 
was the same by all techniques.  
With regard to the second set of samples, excellent correlation was obtained between data 
provided by the present biosensor for both conjugate concentrations (y=1.07x-0.39; 
R²=0.998), with no significant statistical difference (P=0.902; T=51.00). As for the first set of 
samples, data provided by the biosensor using 100 µg mL-1 of conjugate was used for further 
comparison. As observed in other works [27], TTX concentrations determined by the planar 
waveguide biosensor were generally slightly lower than those reported by MBA, but the data 
were still in good agreement (y=0.74x+0.42; R²=0.987), with the differences statistically not 
significant (P=1.000; T=27.000). The overestimation of the TTX contents provided by MBA 
is attributed to the different principle of the techniques; specifically, MBA reports global 
toxicity using animal models and could detect co-existing toxins other than TTXs. Moreover, 
since no cross-reactivity data of the TTX analogues is available for this biosensor and 
antibody and toxin equivalency factors (TEFs) are not well-established, the biosensor 
response was not necessarily expected to fully match the MBA data.  
Different scenarios were assumed when comparing the TTX contents obtained with the 
current biosensor to those determined by LC-MS/MS analysis. If only individual TTX is 
evaluated, the data correlated quite well (R2=0.945) but much higher TTX contents were 
determined by the biosensor (y=3.16x+0.76). These differences in the concentrations, 
although statistically not significant (P=0.310; T=1.109), seem to indicate that some of the 
TTX analogues detected in the LC-MS/MS were also recognized by the antibody. In the 
second scenario, TTX analogues were considered to have the same mAb affinity as TTX, 
thus with a cross-reactivity factor (CRF) of 1. Unfortunately, worse correlation (R2=0.702) 
and higher overestimation (y=8.83x+28.91) were obtained compared to LC-MS/MS analysis 
using this scenario. This underestimation of LC-MS/MS analysis with respect to the planar 
waveguide biosensor suggests that not all the TTX analogues were recognized by the 
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antibody in the MBio biosensor, or they are recognized with low affinity. Looking at the LC-
MS/MS individual concentrations, it seems evident that the analogues 5,6,11-trideoxy-TTX 
(1 and 2) cannot be recognized by the antibody at the same extent as TTX (i.e., much higher 
quantifications would have been obtained with the planar waveguide biosensor for 7.A (GI 
tract) and 7.B (liver) samples). Moreover, this analogue has been considered almost non-
toxic by other authors [52]. 
As an intermediate approach, only 4-epiTTX, 4,9-anhydroTTX, 5-deoxyTTX and 11-
deoxyTTX were theorized to be recognized by the antibody with same affinity than TTX. In 
this case, excellent correlations (R2=0.954) and similar quantifications (y=1.07x+0.68) were 
obtained between MBio biosensor and LC-MS/MS analysis (P=0.690; T=30.000). Of course, 
this criterion was used only to demonstrate that results can change to a high extent 
depending on the analogues considered. Ideally, and according to what has been previously 
published [27], to better compare the concentrations obtained by the biosensor to that 
provided by LC-MS/MS, CRFs of the antibody towards co-existing TTX analogues should 
be established and applied to the individual measurements determined by LC-MS/MS. 
Unfortunately, TTX analogue standards were not available to investigate this issue in detail. 
As for the general results, the biosensor, MBA and LC-MS/MS were in agreement in 
determining the gastrointestinal tract as the most toxic tissue, followed by the liver tissue of 
L. sceleratus species. Due to the low TTX content, it was more difficult to observe a trend in 
muscle and skin tissues by the different methods used herein.  
Notably, the present biosensor was proven to be useful as screening tool and was also 
capable of rapidly (in 10 min) detecting trace TTX contents, thereby meeting the 
requirements in terms of sensitivity not only of the Japanese regulation but also of the similar 
mode-of-action PSP toxins legislation. 
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4. Conclusions 
The present work reported the development of a rapid and specific nanoarray planar 
waveguide biosensor for the determination of TTX concentration in puffer fish samples. The 
biosensor attained good sensitivity (LOD of 2.5 µg L-1), thus being capable of detecting TTXs 
as low as 0.4 µg g-1 puffer fish. This concentration is below the EU and US regulatory limit 
of 0.8 µg STX equiv. g-1 shellfish meat for the similar PSP toxins and can be used as a guide. 
Additionally, the negligible effects of puffer fish matrix on the biosensor and the excellent 
toxin recoveries obtained reinforce the reliability and applicability of the innovative method. 
This is further evidenced by the general agreement found between the TTX concentrations 
determined by the biosensor and the other methods (LC-MS/MS, RBA, ELISA, MBA and 
SPR biosensor) in the analysis of naturally-contaminated puffer fish samples of different 
species.  
This biosensor configuration presents multiple benefits, including simplicity and rapidity of 
the assay, design versatility, small reagent volumes, good reproducibility, and accurate and 
precise toxin quantifications. In addition to these advantages, this nanoarrayed configuration 
could be used together with other related toxins for simultaneous multi-toxin detection, which 
represents a breakthrough in the development of compact, multiplexed devices. Despite the 
planar waveguide technology not being new per se, this is the first immunosensor using this 
technique that has been specifically developed for TTX. Thus, this new approach can be 
considered as a proof of concept, being not only applicable to TTX but also to other emerging 
toxins of seafood safety and environmental surveillance fields.  
On the whole, the biosensor described herein has been proven to be a promising high-
throughput sample screening tool for implementation in research and monitoring programs, 
being able to analyze multiple samples with toxin contents below the permitted levels of 
concern. Furthermore, taking into consideration the presence of TTX recently reported in 
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European shellfish mollusks of England, Greece and Netherlands, the biosensor developed 
herein could have suitable sensitivity, at lower proposed action levels, to be applicable to 
shellfish by only slightly modifying the sample preparation. 
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Figure 1. Schematic representation of the planar waveguide immunosensor for 
TTX. 
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Figure 2. Calibration curves in buffer and fortified-puffer fish tissues and extracts 
obtained for a) 50 µg mL-1 and b) 100 µg mL-1 TTX-conjugate. Curves normalized 
to mAb signal when no TTX is present. Standard deviations for 16 replicates are 
represented by the error bars. 
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Table 1. Midpoint of the curve (IC50), LOD (IC20) and dynamic range (IC20−IC80) 
values ± SD provided by the planar waveguide biosensor in buffer for both TTX 
conjugate concentrations and for 16 replicates. 
 
[TTX conjugate] Midpoint (IC50) µg L-1 LOD (IC20) µg L-1 Dynamic range (IC20-IC80) µg L-1 
50 µg mL-1 6.1 ± 0.5 2.5 ± 0.1 2.5 (± 0.1)-20.5 (± 2.2) 
100 µg mL-1 5.8 ± 0.3 2.6 ± 0.1 2.6 (± 0.1)-15.2 (± 1.7) 
 
 
Table 2. TTX concentration ± standard deviation for 16 replicates in fortified-
puffer fish tissue and extracts determined by the planar waveguide biosensor. 
Toxin recovery is expressed in percentages (%) and calculated with reference 
to the TTX fortification levels of 0.4 and 0.8 µg TTX g-1 puffer fish.  
 
 
 
 
 
 
 
[TTX conjugate] Matrix 
TTX fortification level 
0.8 µg g-1 0.4 µg g-1 
50 µg mL-1 
fortified-puffer fish tissue 0.82 ± 0.03 (102.5%) 0.35 ± 0.02 (87.5%) 
fortified-puffer fish extract 0.78 ± 0.06 (97.5%) 0.40 ± 0.09 (100.0%) 
100 µg mL-1 
fortified-puffer fish tissue 0.81 ± 0.03 (101.3%) 0.35 ± 0.05 (87.5%) 
fortified-puffer fish extract 0.77 ± 0.06 (96.3%) 0.38 ± 0.01 (95.0%) 
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Table 3. TTX concentration (µg TTX g-1 puffer fish tissue) determined in a) 5 sample tissues from L. lunaris and b) 7 sample tissues from 
L. sceleratus by the MBio biosensor and comparison with other methods [46-48]. 
 
a)  
 
 
 
 
 
 
 
b) 
 
LOQ: 0.32 µg g-1; LOD: 0.08 µg g-1; n.d.: not detected 
µg TTX g-1 puffer fish tissue 
Sample code MBio biosensor LC-MS/MS 
(TTX) [46] 
RBA  
[46] 
ELISA 
[46] 
SPR 
[46] TTX conjugate 50 µg mL-1 TTX conjugate 100 µg mL-1 
1 0.27 ± 0.07 0.31 ± 0.04 0.10 0.18 0.04 0.07 
2 3.38 ± 0.08 3.23 ± 0.15 2.14 3.52 2.68 2.47 
3 13.26 ± 0.64 13.49 ± 0.64 8.76 10.50 14.12 7.09 
4 19.02 ± 5.19 17.50 ± 5.03 9.61 13.24 12.48 10.74 
5 0.24 ± 0.03 0.24 ± 0.07 0.10 0.16 0.02 0.07 
µg TTX g
-1
 puffer fish tissue 
 
Sample code 
MBio biosensor 
MBA [47] 
LC-MS/MS [48] 
TTX conjugate 
50 µg mL-1 
TTX conjugate 
100 µg mL-1 
TTX 4-epiTTX 
4,9-
anhydroTTX 
5-
deoxyTTX 
11-
deoxyTTX 
11-
norTTX-
6(R)-ol 
11-
norTTX-
6(S)-ol 
5,6,11- 
trideoxyTTX (1) 
5.6.11- 
trideoxyTTX (2) 
6 2.71 ± 0.79 2.73 ± 0.54 1.69 <LOQ <LOD <LOD <LOD <LOQ <LOQ <LOQ 1.20 2.30 
7.A 41.07 ± 8.49 43.72 ± 4.88 56.78 12.05 2.96 1.97 3.67 17.45 3.53 16.50 109.75 220.75 
7.B 10.18 ± 1.64 9.08 ± 0.99 16.12 2.39 0.47 0.52 0.76 2.55 0.36 4.38 94.00 192.25 
7.C 2.99 ± 0.49 3.07 ± 0.33 2.42 0.65 <LOD <LOQ <LOQ 0.56 1.08 0.83 23.55 56.50 
8.A 6.64 ± 0.72 6.73 ± 0.84 10.84 4.20 0.46 0.63 1.62 5.50 3.16 8.70 0.71 4.07 
8.B 1.34 ± 0.45 1.34 ± 0.24 <1.10 <LOQ <LOD <LOD <LOD <LOQ <LOQ <LOQ <LOQ <LOQ 
8.C 1.41 ± 0.23 1.41 ± 0.07 <1.10 <LOQ n.d. <LOD <LOQ 0.54 0.47 0.48 <LOQ <LOQ 
